3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
16
Plasma cell
2
Thoracic
1
Other hematologic neoplasm
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
CNS
1
Conditions
Lung Neoplasms
2
Venous Thromboembolism
1
Thrombosis
1
Thromboembolism
1
Prostatic Neoplasms
1
Neoplasms
1
Inflammation
1
Immune System Diseases
1
Colonic Neoplasms
1
Cardiovascular Diseases
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
Tinzaparin
2
Fondaparinux
2
sotorasib
1
Rivaroxaban
1
Nadroparin
1
Gemcitabine
1
Drug Therapy
1
Dalteparin
1
ALT-836
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Venous Thromboembolism
×
Rivaroxaban
×
Thoracic
×
Clear all
NCT06314763
2024-04-30
ROSIE
Radboud University Medical Center
Phase 4
Completed
21 enrolled